Efficacy and safety of odevixibat over 72 weeks of treatment in patients with progressive familial intrahepatic cholestasis

Richard J. Thompson; Emmanuel Gonzalès; Reha Artan; Winita Hardikar; Florence Lacaille; Alain Lachaux; Bertrand Roquelaure; Ulrich Baumann; Ekkehard Sturm; Eyal Shteyer; Pier Luigi Calvo; Henkjan J. Verkade; Mohammad Ali Shagrani; Janis M. Stoll; Piotr Czubkowski; Buket Dalgıç; Girish Gupte; Tassos Grammatikopoulos; Patrick McKiernan; Qifeng Yu; Lise Kjems; Patrick Horn

doi:10.1016/S0168-8278(22)01365-4

Back

Efficacy and safety of odevixibat over 72 weeks of treatment in patients with progressive familial intrahepatic cholestasis

Journal article

Peer reviewed

Efficacy and safety of odevixibat over 72 weeks of treatment in patients with progressive familial intrahepatic cholestasis

Richard J. Thompson, Emmanuel Gonzalès, Reha Artan, Winita Hardikar, Florence Lacaille, Alain Lachaux, Bertrand Roquelaure, Ulrich Baumann, Ekkehard Sturm, Eyal Shteyer, …

Journal of hepatology, Vol.77, pp.S521-S521

07/2022

DOI: https://doi.org/10.1016/S0168-8278(22)01365-4

Metrics

1 Record Views

Details

Title: Efficacy and safety of odevixibat over 72 weeks of treatment in patients with progressive familial intrahepatic cholestasis
Creators - without role: Richard J. Thompson
Emmanuel Gonzalès
Reha Artan
Winita Hardikar
Florence Lacaille
Alain Lachaux
Bertrand Roquelaure
Ulrich Baumann
Ekkehard Sturm
Eyal Shteyer
Pier Luigi Calvo
Henkjan J. Verkade
Mohammad Ali Shagrani
Janis M. Stoll
Piotr Czubkowski
Buket Dalgıç
Girish Gupte
Tassos Grammatikopoulos
Patrick McKiernan
Qifeng Yu
Lise Kjems
Patrick Horn
Publication Details: Journal of hepatology, Vol.77, pp.S521-S521
Identifiers: 9913111008331
Academic Unit: Alfaisal University; King Faisal University
Language: English
Resource Type: Journal article